Acute neurologic dysfunction associated with high-dose chemotherapy and autologous bone marrow rescue for primary malignant brain tumors

Pediatric Neurosurgery

Volumn 27, Issue 5, 1997, Pages 230-237

  Kramer, Eric D ^a   Packer, Roger J ^a   Ginsberg, Jill ^a   Goldman, Stuart ^a   Thompson, Stephen ^a   Bayer, Usa A ^a   Shen, Violet ^a   Harris, Richard ^a   Khan, Shakila ^a   Finlay, Jonathan L ^a  

^a Department of Anesthesiology   (United States)

Author keywords

Autologous bone marrow rescue; Brain tumors, childhood; Encephalopathy; Neurologic complications of cancer; Neurotoxicity

Indexed keywords

ANTINEOPLASTIC AGENT; DEXAMETHASONE;

ADOLESCENT; ADULT; ARTICLE; ATAXIA; BONE MARROW RESCUE; BRAIN CANCER; BRAIN DISEASE; CANCER CHEMOTHERAPY; CHILD; COMA; DOSE TIME EFFECT RELATION; DYSARTHRIA; FEMALE; HALLUCINATION; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PRIORITY JOURNAL; SEIZURE; TREMOR;

EID: 7144261048     PISSN: 10162291     EISSN: 14230305     Source Type: Journal    
DOI: 10.1159/000121259     Document Type: Article

References (20)

1. Advison-Committee of the International Autologous Bone Marrow Transplant Registry (ABMTR): Autologous bone marrow transplants: Different indications in Europe and North America. Lancet 1989:2:317-318.
2. Chcson BD, Lacccrna L, Levland-Honcs B, Sa-rosy G, Wittes RE: Autologous bone marrow transplantation. Ann Intern Med 1989:110:51-65.
3. Hildebrand J. Badjou A. Collard-Ronge E. Del-forge A. Malarmc M, Sprio T. Sztem B. Van-denstcene A, Strvckmans PA: Treatment of brain gliomas with high dose CCNU and autologous bone marrow transplantation. Biomedicine 1980:32:71-75.
4. Mortimer JE, Hewlett JS. Livingston RB: High-dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas. J Neurooncol 1983:1:269-273.
5. Johnson DB. Thompson JM, Corwin JA. Mosley KR. Smith MT, dc Los Reyes RA, Daly MB, Petty AM. Lamaster D. Pierson WP. Ruxer RL. Leff RS, Messerschmidt GL: Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation. J Clin Oncol 1987;5:783-789.
6. Finlay JL. Goldman S. Wong MC, Cairo M. Garvin J. August CS, Cohen BH. Stanley P, Zimmerman RA. Bostroin B, Geyer JR. Harris RE. Sanders J, Yates AJ. Boyett J. Packer RJ: Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. J Clin Oncol 1996:14:2495-2503.
7. Finlay JL: High-dose chemotherapy followed by bone marrow ‘rescue' for recurrent brain tumors: in Packer RJ. Blcyer WA. Pochcdly C (eds): Pediatric Neuro-Oncology: New Trends in Clinical Research. Philadelphia, Harwood Academic Publishers. 1992, pp 278-297.
8. Wiznitzer M. Packer RJ, August CS, Burkey ED: Neurologic complications of bone marrow transplantation in childhood. Ann Neurol 1984;16:569-576.
9. Patchell RA. White CL, Clark AW. Beschorncr WE, Santos GW: Neurologic complications of bone marrow transplantation. Neurology 1985; 35:300-306.
10. Snider S. Bashir R. Bicrman P: Neurologic complications after high-dose chemotherapy and autologous bone marrow transplantation for Hodgkin’s disease. Neurology 1994:44: 681-684.
11. Lazarus HM. Reed MD. Spitzer TR. Rabaa S. Blunter JL: High-dose IV thiotepa and ervopre-served autologous bone marrow transplantation for refractory cancer. Cancer Treat Rep 1987;71:689-694.
12. Wolff SN. Johnson DH. Hainsworth JD. Greco A: High-dose VP-16-213 monotherapy for refractory germinal malignancies: A phase II study. J Clin Oncol 1984;2:271-274.
13. Mbiddc EK. Selby PJ. Perren TJ. Dcamaley DP. Whitton A. Ashley S. Workman P. Bloom HJG, McEKvain TJ: High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma. Br J Cancer 1988:58:779-782.
14. Gilmore RL: Seizures and antiepileptic drug use in transplant patients. Neurol Clin 1988;6: 279-296.
15. Davis DG, Patchell RA: Neurologic complications of bone marrow transplantation. Neurol Clin 1988:6:377-388.
16. Ghosh C, Lazarus HM. Hewlett JS. Cregime-ner RJ: Fluctuation of serum phenytoin concentrations during autologous bone marrow transplant for primary central nervous system tumors. J Neurooncol 1992:12:25-32.
17. Heideman RL, Douglass EC. Krance RA. Fon-tanesi J, Langston JA. Sanford RA, Kovnar EH, Ochs J, Kultesch J, Jenkins JJ: High-dose chemotherapy and autologous bone-marrow rescue followed by interstitial and external-beam radiotherapy in newly diagnosed pediatric malignant gliomas. J Clin Oncol 1993:11: 1458-1465.
18. Leff RS, Thompson JM. Daly MB. Johnson DB, Harden EA. Mcrcicr RJ, Messerschmidt GL: Acute neurologic dysfunction after high-dose etoposide therapy for malignant glioma. Cancer 1988;62:32-35.
19. Burger PC. Kamenar E. Schold CS: Encephalo-myciopathy following high-dose BCNU therapy. Cancer 1981;48:1318-1327.
20. George D, Ginsberg J. Weingast R. Papadakis V, Gillio AP. Papadopoulos E. Heller G, Finlay JL: Multi-organ system failure syndrome in patients undergoing mycloablativc chemotherapy and autologous bone marrow rescue for malignant brain tumors (abstract). Exp Hematol 1994:22:779.